BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil. 2010;16:8-21. [PMID: 20535321 DOI: 10.5056/jnm.2010.16.1.8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Choi JM, Yang JI, Kang SJ, Han YM, Lee J, Lee C, Chung SJ, Yoon DH, Park B, Kim YS. Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study. J Neurogastroenterol Motil 2018;24:593-602. [PMID: 30347938 DOI: 10.5056/jnm18069] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
2 Krznaric Z, Ljubas Kelecic D, Rustemovic N, Vranesic Bender D, Ostojic R, Markos P, Scarpignato C. Pharmaceutical principles of acid inhibitors: unmet needs. Dig Dis 2011;29:469-75. [PMID: 22095012 DOI: 10.1159/000331515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Yang F, Xie X, Li X, Liao H, Zou B. Analysis of Psychological and Gut Microbiome Characteristics in Patients With Non-erosive Reflux Disease. Front Psychiatry 2022;12:741049. [DOI: 10.3389/fpsyt.2021.741049] [Reference Citation Analysis]
4 Deppe H, Mücke T, Wagenpfeil S, Kesting M, Rozej A, Bajbouj M, Sculean A. Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients. BMC Oral Health 2015;15:84. [PMID: 26208714 DOI: 10.1186/s12903-015-0069-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Fass R. Therapeutic options for refractory gastroesophageal reflux disease. J Gastroenterol Hepatol. 2012;27 Suppl 3:3-7. [PMID: 22486864 DOI: 10.1111/j.1440-1746.2012.07064.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
6 Matsuki N, Fujita T, Watanabe N, Sugahara A, Watanabe A, Ishida T, Morita Y, Yoshida M, Kutsumi H, Hayakumo T. Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population. J Gastroenterol. 2013;48:340-349. [PMID: 22911169 DOI: 10.1007/s00535-012-0649-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
7 Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol. 2010;105:2153-2162. [PMID: 20571493 DOI: 10.1038/ajg.2010.251] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hershcovici T, Jha LK, Fass R. Comparison of Distribution of Intraesophageal pH During Nighttime Recumbency Among Patients With Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 2012;46:562-6. [DOI: 10.1097/mcg.0b013e318248f631] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
9 Park HJ, Lim CS, Kim ES, Han JH, Lee TH, Chun HJ, Cho BR. Measurement of pH Values in Human Tissues by Two-Photon Microscopy. Angew Chem Int Ed 2012;51:2673-6. [DOI: 10.1002/anie.201109052] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
10 Goldani HA, Nunes DL, Ferreira CT. Managing gastroesophageal reflux disease in children: The role of endoscopy. World J Gastrointest Endosc 2012; 4(8): 339-346 [PMID: 22912907 DOI: 10.4253/wjge.v4.i8.339] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Fass R. Alternative therapeutic approaches to chronic proton pump inhibitor treatment. Clin Gastroenterol Hepatol. 2012;10:338-345; quiz e39-40. [PMID: 22178462 DOI: 10.1016/j.cgh.2011.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
12 Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Dominguez Muñoz JE, Grundling H, Persson T, Svedberg LE, Keeling N. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease. BMC Gastroenterol. 2016;16:48. [PMID: 27080034 DOI: 10.1186/s12876-016-0448-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
13 Dickman R, Maradey-Romero C, Gingold-Belfer R, Fass R. Unmet Needs in the Treatment of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2015;21:309-19. [PMID: 26130628 DOI: 10.5056/jnm15105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lim CH, Choi MG, Baeg MK, Moon SJ, Kim JS, Cho YK, Park JM, Lee IS, Kim SW, Choi KY. Symptom characteristics and psychosomatic profiles in different spectrum of gastroesophageal reflux disease. Gut Liver 2014;8:165-9. [PMID: 24672658 DOI: 10.5009/gnl.2014.8.2.165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
15 Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476-486. [PMID: 21671968 DOI: 10.1111/j.1365-2036.2011.04742.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 116] [Article Influence: 12.2] [Reference Citation Analysis]
16 Chi ZC. Reflux hypersensitivity. Shijie Huaren Xiaohua Zazhi 2018; 26(15): 885-891 [DOI: 10.11569/wcjd.v26.i15.885] [Reference Citation Analysis]
17 Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17:14-27. [PMID: 21369488 DOI: 10.5056/jnm.2011.17.1.14] [Cited by in Crossref: 146] [Cited by in F6Publishing: 132] [Article Influence: 13.3] [Reference Citation Analysis]
18 Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, Vieth M, Agréus L, Aro P. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52. [PMID: 21946284 DOI: 10.1038/ajg.2011.326] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
19 D'Souza SM, Houston K, Keenan L, Yoo BS, Parekh PJ, Johnson DA. Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria? World J Gastroenterol 2021; 27(18): 2054-2072 [PMID: 34025064 DOI: 10.3748/wjg.v27.i18.2054] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Alecci U, Bonina F, Bonina A, Rizza L, Inferrera S, Mannucci C, Calapai G. Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study. Evid Based Complement Alternat Med 2016;2016:2581461. [PMID: 27818697 DOI: 10.1155/2016/2581461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ribolsi M, Giordano A, Guarino MPL, Tullio A, Cicala M. New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert Review of Gastroenterology & Hepatology 2019;13:761-9. [DOI: 10.1080/17474124.2019.1645596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Kusano M, Fujimoto K, Arakawa T; G-PRIDE Study Group. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol 2014;49:1392-405. [DOI: 10.1007/s00535-013-0896-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
23 Sandhu DS, Fass R. Current Trends in the Management of Gastroesophageal Reflux Disease. Gut Liver 2018;12:7-16. [PMID: 28427116 DOI: 10.5009/gnl16615] [Cited by in Crossref: 87] [Cited by in F6Publishing: 56] [Article Influence: 21.8] [Reference Citation Analysis]
24 Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy. J Gastroenterol 2015;50:298-304. [PMID: 24919745 DOI: 10.1007/s00535-014-0972-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hungin APS, Hill C, Molloy–bland M, Raghunath A. Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 2012;10:109-16. [DOI: 10.1016/j.cgh.2011.07.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
26 Xiao J, Yang Y, Zhu Y, Qin Y, Li Y, Fu M, Zhai Z, Zhu L. Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2018;2018:1505394. [PMID: 29977310 DOI: 10.1155/2018/1505394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
27 Karkon Varnosfaderani S, Hashem-dabaghian F, Amin G, Bozorgi M, Heydarirad G, Nazem E, Nasiri Toosi M, Mosavat SH. Efficacy and safety of Amla ( Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial. Journal of Integrative Medicine 2018;16:126-31. [DOI: 10.1016/j.joim.2018.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Flores L, Krause C, Pokala B, Hosein S, Armijo PR, Mishra T, Kothari S, Oleynikov D. Novel therapies for gastroesophageal reflux disease. Curr Probl Surg 2019;56:100692. [PMID: 31837718 DOI: 10.1016/j.cpsurg.2019.100692] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Frazzoni M, Conigliaro R, Mirante VG, Melotti G. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil. 2012;24:141-146, e87. [PMID: 21988704 DOI: 10.1111/j.1365-2982.2011.01800.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
30 Goh KL, Lee YY, Leelakusolvong S, Makmun D, Maneerattanaporn M, Quach DT, Raja Ali RA, Sollano JD, Tran VH, Wong RK. Consensus statements and recommendations on the management of mild-to-moderate gastroesophageal reflux disease in the Southeast Asian region. JGH Open 2021;5:855-63. [PMID: 34386592 DOI: 10.1002/jgh3.12602] [Reference Citation Analysis]
31 Dunbar KB, Agoston AT, Odze RD, Huo X, Pham TH, Cipher DJ, Castell DO, Genta RM, Souza RF, Spechler SJ. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA 2016;315:2104-12. [PMID: 27187303 DOI: 10.1001/jama.2016.5657] [Cited by in Crossref: 127] [Cited by in F6Publishing: 92] [Article Influence: 21.2] [Reference Citation Analysis]
32 Park E, Choi M, Baeg M, Lim C, Kim J, Cho Y, Park J, Lee I, Kim S, Choi K. The Value of Early Wireless Esophageal pH Monitoring in Diagnosing Functional Heartburn in Refractory Gastroesophageal Reflux Disease. Dig Dis Sci 2013;58:2933-9. [DOI: 10.1007/s10620-013-2728-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
33 Dore MP, Pes GM, Bassotti G, Farina MA, Marras G, Graham DY. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia. Scandinavian Journal of Gastroenterology 2016;51:1281-7. [DOI: 10.1080/00365521.2016.1200137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
34 Parekh PJ, Oldfield EC, Johnson DA. Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium). Expert Opinion on Pharmacotherapy 2014;15:1215-22. [DOI: 10.1517/14656566.2014.911841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Lee JH, Cho YK, Jeon SW, Kim JH, Kim NY, Lee JS, Bak YT; Korean Society of Neurogastroenterology and Motility. [Guidelines for the treatment of gastroesophageal reflux disease]. Korean J Gastroenterol 2011;57:57-66. [PMID: 21350318 DOI: 10.4166/kjg.2011.57.2.57] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
36 Dickman R, Maradey-Romero C, Fass R. The role of pain modulators in esophageal disorders - no pain no gain. Neurogastroenterol Motil 2014;26:603-10. [PMID: 24750261 DOI: 10.1111/nmo.12339] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
37 Jung HK, Choi MG, Baek MK, Wu JCY. Development and Psychometric Assessment of a Self-evaluation Questionnaire for Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2018;24:584-92. [PMID: 30347937 DOI: 10.5056/jnm18085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Shibli F, Kitayama Y, Fass R. Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors. Curr Gastroenterol Rep 2020;22. [DOI: 10.1007/s11894-020-0753-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
39 Hsu Y, Lin H. Addition of prokinetic therapy to a PPI in reflux diseases: Letters to the Editors. Alimentary Pharmacology & Therapeutics 2011;33:983-4. [DOI: 10.1111/j.1365-2036.2011.04595.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Nam SY, Park BJ, Cho YA, Ryu KH. Gender-specific Effect of Micronutrient on Non-erosive Reflux Disease and Erosive Esophagitis. J Neurogastroenterol Motil 2019;25:82-90. [PMID: 30646479 DOI: 10.5056/jnm18114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Nam SY, Park BJ, Cho Y, Ryu KH, Choi IJ, Park S, Kim Y. Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects. J Gastroenterol 2017;52:818-29. [DOI: 10.1007/s00535-016-1282-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
42 Sun J, Yuan YZ, Hou XH, Zou DW, Lu B, Chen MH, Liu F, Wu KC, Zou XP, Li YQ, Zhou LY. Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis. World J Gastroenterol 2015; 21(22): 6965-6973 [PMID: 26078574 DOI: 10.3748/wjg.v21.i22.6965] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Avdeev VG. [Some issues of the diagnosis and treatment of gastroesophageal reflux disease]. Ter Arkh 2015;87:120-4. [PMID: 28635804 DOI: 10.17116/terarkh20158710120-124] [Reference Citation Analysis]
44 Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, Jain R, Appalaneni V, Anderson MA, Ben-Menachem T, Chandrasekhara V. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78:216-224. [PMID: 23867371 DOI: 10.1016/j.gie.2013.04.167] [Cited by in Crossref: 81] [Cited by in F6Publishing: 55] [Article Influence: 10.1] [Reference Citation Analysis]
45 Ohmure H, Kanematsu-hashimoto K, Nagayama K, Taguchi H, Ido A, Tominaga K, Arakawa T, Miyawaki S. Evaluation of a Proton Pump Inhibitor for Sleep Bruxism: A Randomized Clinical Trial. J Dent Res 2016;95:1479-86. [DOI: 10.1177/0022034516662245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
46 Gold BD, Pilmer B, Kierkuś J, Hunt B, Perez MC, Gremse D. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease. Dig Dis Sci 2017;62:3059-68. [PMID: 28916953 DOI: 10.1007/s10620-017-4743-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
47 Singh R, Hussain A, Loong CK. Narrow band imaging with magnification for the diagnosis of lesions in the upper gastrointestinal tract. World J Gastrointest Endosc 2013; 5(12): 584-589 [PMID: 24368933 DOI: 10.4253/wjge.v5.i12.584] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
48 Yamasaki T, Fass R. Reflux Hypersensitivity: A New Functional Esophageal Disorder. J Neurogastroenterol Motil 2017;23:495-503. [PMID: 28992673 DOI: 10.5056/jnm17097] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]
49 Hershcovici T, Jha LK, Fass R. Dexlansoprazole MR: a review. Ann Med 2011;43:366-74. [PMID: 21366513 DOI: 10.3109/07853890.2011.554429] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
50 Lynen A, Schömitz M, Vahle M, Jäkel A, Rütz M, Schwerla F. Osteopathic treatment in addition to standard care in patients with Gastroesophageal Reflux Disease (GERD) – A pragmatic randomized controlled trial. Journal of Bodywork and Movement Therapies 2022;29:223-31. [DOI: 10.1016/j.jbmt.2021.09.017] [Reference Citation Analysis]
51 Ryu HS, Choi SC. [Minimal Change Esophagitis]. Korean J Gastroenterol 2016;67:4-7. [PMID: 26809625 DOI: 10.4166/kjg.2016.67.1.4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Kim YS, Kim N, Kim GH. Sex and Gender Differences in Gastroesophageal Reflux Disease. J Neurogastroenterol Motil. 2016;22:575-588. [PMID: 27703114 DOI: 10.5056/jnm16138] [Cited by in Crossref: 74] [Cited by in F6Publishing: 57] [Article Influence: 12.3] [Reference Citation Analysis]
53 Kim EJ, Lee OY, Lee KN, Lee SJ, Jang JY, Cho JW, Kim TO. Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. J Neurogastroenterol Motil 2019;25:403-12. [PMID: 31327222 DOI: 10.5056/jnm18185] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Khoury T, Mari A, Amara H, Jabaren M, Watad A, Nseir W, Sbeit W, Mahamid M. Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease. Can J Gastroenterol Hepatol 2019;2019:6415757. [PMID: 30854351 DOI: 10.1155/2019/6415757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
55 Shaheen NJ, Adler J, Dedrie S, Johnson D, Malfertheiner P, Miner P, Meulemans A, Poole L, Tack J, Thielemans L, Troy S, Vakil N, Zerbib F, Ruth M. Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy. Aliment Pharmacol Ther 2015;41:649-61. [PMID: 25693609 DOI: 10.1111/apt.13115] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
56 Park CH, Seo SI, Kim JS, Kang SH, Kim BJ, Choi YJ, Byun HJ, Yoon JH, Lee SK. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study. Sci Rep 2020;10:15154. [PMID: 32938975 DOI: 10.1038/s41598-020-72082-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wang K, Duan LP, Zeng XZ, Liu JY, Xu-Chu W. Differences in cerebral response to esophageal acid stimuli and psychological anticipation in GERD subtypes--an fMRI study. BMC Gastroenterol 2011;11:28. [PMID: 21439078 DOI: 10.1186/1471-230X-11-28] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
58 Park JM, Chi KC. Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease. Ann Surg Treat Res 2018;95:94-9. [PMID: 30079326 DOI: 10.4174/astr.2018.95.2.94] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Aitella E, De Bartolomeis F, Savoia A, Fabiani M, Romano M, Astarita C. The overlap syndrome of urticaria and gastroesophageal reflux disease. PLoS One 2018;13:e0207602. [PMID: 30458030 DOI: 10.1371/journal.pone.0207602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
60 Park HJ, Lim CS, Kim ES, Han JH, Lee TH, Chun HJ, Cho BR. Measurement of pH Values in Human Tissues by Two-Photon Microscopy. Angew Chem 2012;124:2727-30. [DOI: 10.1002/ange.201109052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
61 Matsuhashi N, Kudo M, Yoshida N, Murakami K, Kato M, Sanuki T, Oshio A, Joh T, Higuchi K, Haruma K. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study. J Gastroenterol. 2015;50:1173-1183. [PMID: 25851931 DOI: 10.1007/s00535-015-1073-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
62 Calabrese C, Montanaro L, Liguori G, Brighenti E, Vici M, Gionchetti P, Rizzello F, Campieri M, Derenzini M, Trerè D. Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease. World J Gastroenterol 2011; 17(40): 4496-4502 [PMID: 22110280 DOI: 10.3748/wjg.v17.i40.4496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Chen GW, Xie S, Lian YH, Chen JK. Psychological intervention for auxiliary treatment of non-erosive reflux disease. Shijie Huaren Xiaohua Zazhi 2016; 24(32): 4375-4380 [DOI: 10.11569/wcjd.v24.i32.4375] [Reference Citation Analysis]
64 Wu CL, Chen CL, Wen SH. Profile of the Change in Depression during Proton-Pump Inhibitor Therapy in Patients with Gastroesophageal Reflux Disease: Influence of the Mucosal Break. Int J Environ Res Public Health 2021;18:5964. [PMID: 34199477 DOI: 10.3390/ijerph18115964] [Reference Citation Analysis]
65 Maradey-Romero C, Fass R. New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil. 2014;20:6-16. [PMID: 24466441 DOI: 10.5056/jnm.2014.20.1.6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
66 Lim CS, Cho BR. Two-photon probes for biomedical imaging. Tetrahedron 2015;71:8219-49. [DOI: 10.1016/j.tet.2015.06.083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
67 Vigneri S, Bonventre S, Inviati A, Schifano D, Cosentino G, Puma A, Giglia G, Paladino P, Brighina F, Fierro B. Effects of transcranial direct current stimulation on esophageal motility in patients with gastroesophageal reflux disease. Clinical Neurophysiology 2014;125:1840-6. [DOI: 10.1016/j.clinph.2013.12.110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
68 Lim CS, Cho BR. Two-photon probes for biomedical applications. BMB Rep 2013;46:188-94. [PMID: 23615259 DOI: 10.5483/bmbrep.2013.46.4.045] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
69 Melendez-Rosado J, Gutierrez-Blanco D, Schneider A, Menzo EL, Szomstein S, Rosenthal RJ. Impact of preoperative wireless pH monitoring in the evaluation of esophageal conditions prior to bariatric surgery in a severely obese patient population. Surg Obes Relat Dis 2019;15:288-94. [PMID: 30642753 DOI: 10.1016/j.soard.2018.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
70 Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease--a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25:399-406, e295. [PMID: 23360178 DOI: 10.1111/nmo.12080] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 9.2] [Reference Citation Analysis]
71 Jin EH, Park B, Kim YS, Choe EK, Choi SH, Kim JS, Jung SA. A Novel Susceptibility Locus Near GRIK2 Associated With Erosive Esophagitis in a Korean Cohort. Clin Transl Gastroenterol 2020;11:e00145. [PMID: 32132452 DOI: 10.14309/ctg.0000000000000145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Kim JY, Shin IS, Min YW, Kim K, Lee H, Min BH, Lee JH, Kim JJ, Rhee PL. Endoscopic Prediction for Acid Reflux in Patients without Hiatus Hernia. Korean J Gastroenterol 2020;76:134-41. [PMID: 32969361 DOI: 10.4166/kjg.2020.76.3.134] [Reference Citation Analysis]
73 Gabbard SL, Fass R, Maradey-Romero C, Gingold Belfer R, Dickman R. Identifying Minimal Changes in Nonerosive Reflux Disease: Is the Pay Worth the Labor? J Clin Gastroenterol 2016;50:11-6. [PMID: 26444647 DOI: 10.1097/MCG.0000000000000423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Maradey-Romero C, Kale H, Fass R. Nonmedical therapeutic strategies for nonerosive reflux disease. J Clin Gastroenterol. 2014;48:584-589. [PMID: 25000345 DOI: 10.1097/MCG.0000000000000125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
75 Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 2013;10:371-80. [DOI: 10.1038/nrgastro.2013.50] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 15.6] [Reference Citation Analysis]
76 Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R. The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger? J Neurogastroenterol Motil 2018;24:559-69. [PMID: 30347935 DOI: 10.5056/jnm18140] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 12.5] [Reference Citation Analysis]
77 Niu CY, Zhou YS, Wu FX. Individualized medicine of gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2018; 26(35): 2046-2056 [DOI: 10.11569/wcjd.v26.i35.2046] [Reference Citation Analysis]
78 Chen CL, Hsu PI. Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract. 2013;2013:653989. [PMID: 23935610 DOI: 10.1155/2013/653989] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
79 Oh JH. Gastroesophageal reflux disease: recent advances and its association with sleep: GERD and sleep. Ann N Y Acad Sci 2016;1380:195-203. [DOI: 10.1111/nyas.13143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
80 Maradey-Romero C, Fass R. Antidepressants for functional esophageal disorders: evidence- or eminence-based medicine? Clin Gastroenterol Hepatol 2015;13:260-2. [PMID: 25283580 DOI: 10.1016/j.cgh.2014.09.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
81 Xu X, Li Z, Zou D, Yang M, Liu Z, Wang X. High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease. Dig Dis Sci. 2013;58:53-60. [PMID: 22961239 DOI: 10.1007/s10620-012-2308-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
82 Niimi A. Cough associated with gastro-oesophageal reflux disease (GORD): Japanese experience. Pulm Pharmacol Ther 2017;47:59-65. [PMID: 28506663 DOI: 10.1016/j.pupt.2017.05.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
83 Shimatani T, Sugimoto M, Nishino M, Adachi K, Furuta K, Ito M, Kurosawa S, Manabe N, Mannen K, Hongo M, Chiba T, Kinoshita Y; the Acid-Related Symptom Research (ARS) Group. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring: Intraesophageal 2-channel pH monitoring. Journal of Gastroenterology and Hepatology 2012;27:899-906. [DOI: 10.1111/j.1440-1746.2011.06975.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
84 Kriengkirakul C, Patcharatrakul T, Gonlachanvit S. The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients. J Neurogastroenterol Motil. 2012;18:174-180. [PMID: 22523726 DOI: 10.5056/jnm.2012.18.2.174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]